Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

1975 • 3,075 citations

The chemical structure of prostaglandin X (prostacyclin)

1976 • 729 citations

An Experimental Study in Dogs

1990 • 666 citations

Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo

1981 • 511 citations

Rapid calculation of radioimmunoassay results.

1969 • 398 citations

Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's Disease

1981 • 314 citations

Plasminogen activator release during venous stasis and exercise as determined by a new specific assay

1983 • 238 citations

An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease

1983 • 211 citations

Determination of tissue plasminogen activator and its "fast" inhibitor in plasma.

1986 • 187 citations

Three Approaches to the Radioimmunoassay of Human β-Thromboglobulin

1976 • 124 citations

AHF Related Protein in Clinical Praxis

1974 • 106 citations

The in vivo release of human platelet factor 4 by heparin

1982 • 99 citations

Heparin-induced Thrombocytopenia

1986 • 99 citations

The Platelet Aggregating Effect of Eight Commercial Heparins

1972 • 93 citations

Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis

1983 • 90 citations

Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1∝ and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs

1984 • 67 citations

Effect of heparin on platelet aggregation

1984 • 67 citations

PLATELET PROAGGREGATING EFFECT OF HEPARIN: POSSIBLE MECHANISM FOR NON‐IMMUNE HEPARIN‐ASSOCIATED THROMBOCYTOPENIA

1986 • 56 citations

Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture.

1984 • 53 citations

Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222)

1987 • 52 citations

Effect of injected heparin on platelet levels in man

1968 • 51 citations

Development of a GC-MS method for quantitation of 2, 3-dinor-TXB2 and determinations of the daily urinary excretion rates in healthy humans

1984 • 46 citations

White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases.

1987 • 40 citations

The Antithrombotic Effect of Heparin in Deep Venous Thrombosis: Relation to Four Heparin Assays

1984 • 36 citations

Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate

1984 • 34 citations

Increased fibrinolytic activity after surgery induced by low dose heparin

1987 • 25 citations

tPA inhibitor, tPA:Ag, plasminogen, and α2-antiplasmin after low molecular weight heparin or standard heparin

1987 • 24 citations

Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis

1985 • 17 citations

The Heparin-Mobilisable Pool of Platelet Factor 4: A Comparison of Intravenous and Subcutaneous Heparin and Kabi Heparin Fragment 2165

1985 • 15 citations